Shahram Seyedin-Noor Overview

  • Investor Type
  • Angel

  • Investments
  • 5

  • Portfolio
  • 4

  • Exits
  • 1


Shahram Seyedin-Noor General Information


Mr. Shahram Seyedin-Noor is the Founder and serves as Managing Partner at Civilization Ventures. He is also a Co-Founder at Rgenix and previously served as an Advisor. He also serves as a Board Member at Foresight Diagnostics. He was previously its Executive Chairman and Chief Business Officer. Prior to Rgenix, Mr. Seyedin-Noor was a founding executive at NextBio, a pioneer in genomics data analysis and personalized medicine. NextBio was acquired by Illumina in 2013 (NASDAQ: ILMN). Mr. Seyedin-Noor helped grow NextBio into a profitable leader in the life sciences with millions in revenues from top-tier customers such as Merck, Celgene, J&J, Regeneron, Pfizer and nearly every other major biotech/pharma company. He is also an angel investor in various innovative healthcare startups, including Avantome (acq. by Illumina), Bina Technologies (acq. by Roche), Counsyl and Omada Health, among others. Prior to founding Civilization Ventures, he was an entrepreneur and angel investor. He is a founding executive in several life sciences companies, including Rgenix, a biotech company with first-in-class therapeutics for cancer, now in Phase 1 clinical trials. Prior to Rgenix, he was founding CFO and VP of Corporate Development at NextBio, a genomics big data analytics pioneer acquired by Illumina in 2013. He is also a seed investor in category-defining startups such as Omada Health and Counsyl. He began his career in Silicon Valley as a startup counsel at Wilson Sonsini Goodrich & Rosati, and later as a high-tech investment banker at Goldman Sachs. He earned his JD from Harvard Law School, where he was elected Editor-in-Chief of the Harvard International Law Journal, and obtained a BA in Economics from Pomona College.

Business Details

Primary Investor Type
Angel (individual)
Corporate Office
  • 595 Pacific Avenue
  • 4th Floor
  • San Francisco, CA 94133
  • United States
+1 (650) 000-0000

Shahram Seyedin-Noor Investments (5)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
BillionToOne 22-Feb-2021 Later Stage VC 0000 Decision/Risk Analysis Generating Revenue 0000000 0000000-0000 00
Manus Bio 06-Nov-2020 00000 00000 0000 Biotechnology Generating Revenue 0000000 0000000-0000 00
Aspect Biosystems 01-Jun-2020 00000 00000 0000 Biotechnology Generating Revenue 0000000 0000000-0000 00
Catalog (Biotechnology) 07-Jul-2017 Seed Round 000 Biotechnology Generating Revenue 0000000 0000000-0000 00
Eversnap 09-Jul-2013 Seed Round Multimedia and Design Software Generating Revenue 0000000 0000000-0000 00

Shahram Seyedin-Noor Exits (1)

Company Name Exit Date Exit Type Exit Size
Eversnap 19-Aug-2020 000000000000000000

Shahram Seyedin-Noor Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Shahram Seyedin-Noor Team (1)

Name Title Deals Funds Boards Office
Shahram Seyedin-Noor JD Angel Investor 00 0 0 San Francisco, CA

Shahram Seyedin-Noor Co-Investors (47)

Name With Exits Lead Partner Series Industry
500 Global 1 0 Series chart Industry bar
Hedgewood 0 0 Series chart Industry bar
Hummingbird Ventures 0 0 Series chart Industry bar
Pangaea Ventures 0 0 Series chart Industry bar
Y Combinator 0 0 Series chart Industry bar

Shahram Seyedin-Noor FAQs

  • Who is Shahram Seyedin-Noor?

    Shahram Seyedin-Noor is an angel Investor who has made 5 investments.

  • What kind of investor is Shahram Seyedin-Noor?

    Shahram Seyedin-Noor is an angel investor.

  • What does Shahram Seyedin-Noor do?

    As an angel investor, Shahram Seyedin-Noor invests personal money into promising companies, typically in exchange for equity.

  • What has Shahram Seyedin-Noor invested in?

    Shahram Seyedin-Noor has made numerous investments in companies like BillionToOne, Manus Bio, and Aspect Biosystems within the Decision/Risk Analysis and Biotechnology industries.

  • What has Shahram Seyedin-Noor invested in recently?

    Shahram Seyedin-Noor's latest investment was on 22-Feb-2021 in BillionToOne, a company within the Decision/Risk Analysis industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »